Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Des Devel Ther. 2011;5:445-54. doi: 10.2147/DDDT.S12139. Epub 2011 Oct 19.

Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.

Author information

1
Department of Rheumatology, Hospital Galateo, San Cesario di Lecce, Italy. mamuratore@libero.it

Abstract

Bisphosphonates have a long history in the treatment of osteoporosis and bone-related disease. This review focuses on the use of a specific nonaminobisphosphonate, clodronate, which appears to be much better tolerated than other bisphosphonates and free of high-risk contraindications. Specifically, this paper reviews its use in the prevention of osteoporosis in postmenopausal women, taking into account its tolerability profile and recent safety issues arising regarding the use of bisphosphonates.

KEYWORDS:

bisphosphonates; bone turnover; clodronate; menopause; osteoporosis; tolerability

PMID:
22087064
PMCID:
PMC3210073
DOI:
10.2147/DDDT.S12139
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Support Center